Inspite of the Inclement Effects of the Healthcare Reform Bill, Global Pharmaceutical Market Is Expected to Mature to $220 billion by 2016
The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. The growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S.
View full press release